Susan Lorey

Summary

Affiliation: Martin Luther University
Country: Germany

Publications

  1. ncbi Transcellular proteolysis demonstrated by novel cell surface-associated substrates of dipeptidyl peptidase IV (CD26)
    Susan Lorey
    Department of Biochemistry and Biotechnology, Institute of Biochemistry, Martin Luther University Halle Wittenberg, Kurt Mothes Strasse 3, D 06120 Halle Saale, Germany
    J Biol Chem 277:33170-7. 2002
  2. ncbi Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites
    Susan Lorey
    Department of Biochemistry Biotechnology, Institute of Biochemistry, Martin Luther University Halle Wittenberg, Halle, Germany
    Eur J Biochem 270:2147-56. 2003

Detail Information

Publications2

  1. ncbi Transcellular proteolysis demonstrated by novel cell surface-associated substrates of dipeptidyl peptidase IV (CD26)
    Susan Lorey
    Department of Biochemistry and Biotechnology, Institute of Biochemistry, Martin Luther University Halle Wittenberg, Kurt Mothes Strasse 3, D 06120 Halle Saale, Germany
    J Biol Chem 277:33170-7. 2002
    ..These data demonstrate that ectopeptidases such as DP IV may be involved in communication between blood cells via proteolysis of cell-associated substrates...
  2. ncbi Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites
    Susan Lorey
    Department of Biochemistry Biotechnology, Institute of Biochemistry, Martin Luther University Halle Wittenberg, Halle, Germany
    Eur J Biochem 270:2147-56. 2003
    ..These findings give new insights for the development of more potent and specific peptide-based DP IV inhibitors. Such inhibitors could be useful for the treatment of autoimmune and inflammatory diseases...